Should the isoproterenol (Isoket) infusion be stopped when the patient develops symptomatic bradycardia or a heart rate below 50 beats per minute?

Do Not Stop Isoket (Isosorbide Dinitrate) for Bradycardia - You're Likely Confusing It With Isoproterenol

You should NOT stop "Isoket" (isosorbide dinitrate) for bradycardia because Isoket is a nitrate vasodilator, not a chronotropic agent that causes bradycardia. However, if you're actually referring to isoproterenol (a beta-agonist sometimes confused with "Isoket"), the situation is entirely different and requires immediate action.

Critical Clarification: Two Different Drugs

If You Mean Isoket (Isosorbide Dinitrate):

• Isoket is a nitrate used for angina and acute coronary syndromes
• Nitrates can cause reflex tachycardia, not bradycardia
• If bradycardia develops during Isoket infusion, it's likely from:
  • The underlying cardiac condition (especially inferior MI with right coronary involvement) 1
  • Concomitant medications (beta-blockers, calcium channel blockers)
  • Vagal reflexes (Bezold-Jarisch reflex from reperfusion)
• The bradycardia noted in ACC/AHA MI guidelines is attributed to morphine or nitroglycerin therapy itself, not as a direct drug effect but as part of the clinical syndrome 1

If You Mean Isoproterenol (Beta-Agonist):

This is the critical scenario requiring immediate intervention.

When to Stop Isoproterenol for Bradycardia

Yes, stop isoproterenol immediately if paradoxical bradycardia develops - this is a rare but well-documented phenomenon occurring in approximately 7% of patients 2.

Mechanism of Paradoxical Bradycardia with Isoproterenol:

Two distinct patterns exist:

1. Vasovagal-mediated bradycardia (most common):

   • Occurs in younger patients (mean age 40 years) without structural heart disease 2
   • Represents hypervagotonia triggered by excessive beta-stimulation
   • Can occur even in supine position without orthostatic stress 3
   • Manifests as sinus or junctional bradycardia with >10% cycle length increase 2

2. Unmasking of conduction disease:

   • Occurs in older patients (mean age 65 years) 2
   • Reveals underlying AV nodal or infranodal conduction abnormalities
   • Presents as second-degree AV block (either supra-Hisian or infra-Hisian) 2
   • This is always pathological and requires permanent pacing evaluation

Management Algorithm for Bradycardia During Isoproterenol

Immediate Actions:

1. Stop the isoproterenol infusion immediately
2. Assess hemodynamic stability (blood pressure, perfusion, mental status) 4
3. Identify if bradycardia is symptomatic (heart rate typically <50 bpm with hypotension, altered mental status, chest pain, or acute heart failure) 4

Treatment Based on Clinical Presentation:

For Symptomatic Bradycardia:

• Atropine 0.5 mg IV, repeat every 3-5 minutes up to total 2 mg 1, 5
  • Effective for sinus bradycardia and AV nodal block
  • Caution: Doses <0.5 mg may paradoxically worsen bradycardia 1
  • Avoid in infranodal block (wide-complex escape rhythm with anterior MI) 1

If Atropine Fails:

• Consider transcutaneous pacing as bridge 1, 4
• Alternative pharmacologic options 5:
  • Dopamine 5-20 mcg/kg/min
  • Epinephrine 2-10 mcg/min 6
  • Theophylline 0.2-0.4 mg/kg/h (especially for atropine-resistant bradycardia in MI) 5

For Asymptomatic Bradycardia:

• Observation only 1
• Do not treat based solely on heart rate number
• Monitor for progression to symptomatic state

Critical Pitfalls to Avoid:

1. Never restart isoproterenol after paradoxical bradycardia - the response indicates either:

   • Excessive vagal sensitivity (benign but precludes further use)
   • Underlying conduction disease requiring pacing evaluation 2

2. Do not use isoproterenol in ischemic conditions - it increases myocardial oxygen demand while decreasing coronary perfusion through beta-2 vasodilation 6, 5

3. Distinguish between drug classes: Isoproterenol causes bradycardia paradoxically; nitrates (Isoket) do not

4. In heart transplant patients: Atropine may cause paradoxical AV block or sinus arrest in 20% of cases due to denervation 6

5. If second-degree AV block develops with isoproterenol: This always indicates organic conduction disease requiring electrophysiology evaluation and likely permanent pacing 2

Special Consideration for Calcium Channel Blocker/Beta-Blocker Overdose:

If bradycardia is from these agents (not isoproterenol-induced), isoproterenol may actually be therapeutic 7. The 2005 ESC guidelines specifically recommend isoproterenol 2-20 mcg/min for bradycardia in acute heart failure, but note it should be avoided in ischemic conditions 5.

Bottom line: Clarify which drug you're actually using. If it's truly isoproterenol causing paradoxical bradycardia, stop it immediately and treat the bradycardia with atropine or pacing as indicated by hemodynamic status.